Description: This session discusses disease management [DM] and the role of health actuaries versus economists and biostatisticians. Topics discussed include economics of DM, epidemiology strategies, and operational concerns. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 21pd.

Description: Preview of the Living to 100 Symposium.

Description: Panelists discuss issues related to special programs used to treat members with known chronic conditions. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: Separating incident and prevalent populations is useful, but the use of a cohort to make an RTM adjustment is unwarranted in the population-based pre- versus post-period design. From Financing Chronic Care Monograph, M-HB05-1.

Description: Most health care delivered in the United States is based on the acute care model: it is episodic has a beginning, middle and end usually the patient recovers and interventions are designed to target a specific pathophysiologic abnormality. Chronic disease care, in contrast, often has no clear beginning and no end the focus is on managing over the long term with prevention of progression and complications. Further, many chronic diseases “travel together” comorbidities: for example, diabetes, hypertension, coronary artery disease CAD, heart failure, cerebrovascular disease, peripheral arterial disease and renal dysfunction are often found together.

Description: This paper presents a different approach to measuring Health Expectancy, especially as it relates to the elderly population. This new actuarial approach is described and numerous examples are given.

Description: Discussion of “Health Expectancy” paper and reply from author, Faye Albert. Discussion of Human Behavior: An Impediment to Future Mortality and Discussion of Health, Wealth and Wisdom - Living Long, Living Well: An Actuary Muses on Longevity

Description: A study of disability experience examines cost burden and degree of disability, and how these measures vary across different subpopulations.

Description: This is the abstract to the paper, A Comparative Analysis of Chronic and Non-Chronic Insured Commercial Member Cost Trends.

Description: This article discusses a study of the impact of the drug infliximab on Crohn's disease patients. This study had been approved in response to an SOA request for proposals for research on the health cost and utilization effects of a specific prescription drug.